News Archive - GOG
The GOG Foundation, Inc. - A Half Century of Transforming The Standard of Care. 50 th Anniversary Book. GOG Partners Connection Quarterly Newsletter - August 2023. Thomas J. Herzog, MD takes office as The GOG Foundation, Inc. President. GOG Partners Connection Quarterly Newsletter - April 2023.
Home - GOG
We conduct clinical and translational research that positively impacts patients through the prevention and treatment of gynecologic malignancies, including cancers that arise from the ovaries, uterus, cervix, vagina, and vulva.
GOG 3026 Press Release - GOG
Mar 25, 2023 · GOG 3026 Press Release - GOG. GOG Partners Investigator Initiated Trial Application. Philadelphia, PA, USA, March 25, 2023, The GOG Foundation, Inc. (GOG) announced positive results from an investigator-initiated phase II trial, sponsored by the GOG, investigating the combination of ribociclib and letrozole in patients with recurrent low-grade ...
The GOG Foundation, Inc., and GOG Partners Press Release - GOG
The GOG Partners and The GOG Foundation, Inc. are thrilled to share a press release for GOG-3023 (InnovaTV 204): A Single Arm, Multicenter, International Trial of Tisotumab Vedotin (HuMAX®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer.
GOG Foundation Announces $3.5 Million Investment In 10 Scholar ...
(PHILADELPHIA, August 1, 2019) – On July 18th the GOG Foundation Education and Mentoring Committee awarded $3.5 million in research grants to 10 scholars and 36 new investigators in gynecologic oncology during the NRG Oncology Semi-Annual Conference in Philadelphia.
News Archive - Page 2 of 5 - GOG
GOG Partners Connection Quarterly Newsletter - October 2022. The GOG Foundation, Inc., the Society of Gynecologic Oncology, and the Foundation for Women’s Cancer announce synergistic partnership to advance the missions of all three organizations.
GOG Foundation COVID-19 Guidance - GOG
A message to GOG Partners Industry Colleagues from Dr. Copeland. A Message from the Biopathology Center. FDA Guidance for Industry, Investigators, and IRBs. Interim Guidance for Patients on Clinical Trials Supported by CTEP and NCORP.
GOG Partners - GOG
Supported by industry, GOG Partners has been structured to work directly with pharmaceutical organizations and operate clinical trials outside the National Cancer Institute (NCI) framework. By providing an alternative venue for patient accrual and site infrastructure support, GOG Partners has helped stabilize the national gynecologic clinical ...
IDEA COMMITMENT - GOG
GOG Efforts of Improving Diversity In Clinical Trials: Access. Maximize ways to increase enrollment of diverse patients by alleviating/removing social and financial barriers- GOG-P trial budgets all include financial compensation to address SDOH
The GOG Foundation, Inc. Board Elects Thomas J. Herzog, MD, as ...
At the NRG Oncology Summer Meeting on July 21, 2022, The GOG Foundation, Inc. (GOG-F) Board of Directors elected Thomas J. Herzog, MD as its next President, succeeding Larry J. Copeland, MD who has served in this role since 2017.